APAC Biotech is a leading biotechnology company specializing in the research and development of personalized immunotherapies for cancer treatment. With over a decade of experience and a dedicated team of scientists and doctors, we are committed to enhancing the immune system's ability to fight cancer through innovative and customized therapeutic solutions. One of our flagship products is APCEDEN®, the only Indian FDA (DCGI) approved personalized dendritic cell immunotherapy for cancer.

This revolutionary treatment activates the patient's immune system to generate a powerful response against the tumor, offering a potentially effective and safe alternative to traditional therapies. In addition to groundbreaking treatments, we also offer the KeepMyTumor tumor banking service, allowing cancer patients to store their tumors for future use with rapidly evolving diagnostic and treatment technologies. At APAC Biotech, our mission is to improve the quality of life for cancer patients.

Our personalized immunotherapies and dedication to innovation are paving the way for a new generation of cancer therapies. Trust in our expertise and join us in the fight against cancer